Mobile Site ›
Print Friendly View

Test ID: HYOX
Hyperoxaluria Panel, Urine

Useful For Suggests clinical disorders or settings where the test may be helpful

Distinguishing between primary and secondary hyperoxaluria

 

Distinguishing between type I and type II primary hyperoxaluria

Genetics Test Information Provides information that may help with selection of the correct test or proper submission of the test request

Distinguishing between primary and secondary hyperoxaluria.

Clinical Information Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test

Increased urinary oxalate frequently leads to renal stone formation. Identification of the cause of increased urinary oxalate is important in the evaluation of the patient with renal oxalate stones or renal insufficiency due to hyperoxaluria and has important implications in therapy and prognosis.

 

Hyperoxalurias have been classified as primary (genetically determined) and secondary. Primary hyperoxalurias are rare autosomally inherited genetic diseases. Type I, a deficiency of peroxisomal alanine:glyoxylate transaminase, is characterized by increased urinary oxalic, glyoxylic, and glycolic acids. Some type I hyperoxaluric patients respond to supplementary pyridoxine therapy. Type II is due to a defect in hydroxypyruvate metabolism (D-glyceric acid dehydrogenase deficiency) and is characterized by an increase in urinary oxalic and glyceric acids.

 

Secondary hyperoxalurias are due to hyperabsorption of oxalate (enteric hyperoxaluria); total parenteral nutrition in premature infants; ingestion of oxalate, ascorbic acid, or ethylene glycol; or pyridoxine deficiency and may respond to appropriate therapy.

Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.

GLYCOLATE

0-31 days: 0-57 mg/g creatinine

1-5 months: 0-54 mg/g creatinine

6-12 months: 0-60 mg/g creatinine

1-5 years: 0-89 mg/g creatinine

> or =6 years: 0-78 mg/g creatinine

 

GLYCERATE

0-31 days: 0-38 mg/g creatinine

1-5 months: 0-71 mg/g creatinine

6-12 months: 0-56 mg/g creatinine

1-5 years: 0-17 mg/g creatinine

> or =6 years: 0-8 mg/g creatinine

 

OXALATE

0-31 days: 0-301 mg/g creatinine

1-5 months: 0-398 mg/g creatinine

6-12 months: 0-280 mg/g creatinine

1-5 years: 0-128 mg/g creatinine

6-10 years: 0-72 mg/g creatinine

> or =11 years: 0-56 mg/g creatinine

 

GLYOXYLATE

0-31 days: 0.0-7.9 mg/g creatinine

1-5 months: 0.0-11.4 mg/g creatinine

6-12 months: 0.0-5.5 mg/g creatinine

1-5 years: 0.0-3.9 mg/g creatinine

> or =6 years: 0.0-2.9 mg/g creatinine

Interpretation Provides information to assist in interpretation of the test results

Increased concentrations of oxalate and glycolate indicate type I hyperoxaluria.

 

Increased concentrations of oxalate and glycerate indicate type II hyperoxaluria.

 

Increased concentrations of oxalate with normal concentrations of glycolate and glycerate indicate secondary hyperoxaluria.

Cautions Discusses conditions that may cause diagnostic confusion, including improper specimen collection and handling, inappropriate test selection, and interfering substances

Ascorbic acid will falsely elevate oxalic acid results.

Clinical Reference Provides recommendations for further in-depth reading of a clinical nature

1. Monico CG, Persson M, Ford GC, et al: Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II. Kidney Int 2002;62:392-400

2. Danpure CJ: Primary hyperoxaluria. In The Metabolic Bases of Inherited Disease. 8th edition. Edited by CR Scriver, AL Beaudet, WS Sly, et al. New York, McGraw-Hill Book Company, 2001, pp 3323-3367

3. Byrd DJ, Latta K: Hyperoxaluria. In Physician’s Guide to the Laboratory Diagnosis of Metabolic Disease. Edited by N Blau, ED Chapman. Hall Medical, 1996, pp 377-390

4. Fraser AD: Importance of glycolic acid analysis in ethylene glycol poisoning. Clin Chem 1998;44(8):1769

Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test